Genazzani AR - Search Results

1

Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.

Genazzani AR, Monteleone P, Giannini A, Simoncini T. Genazzani AR, et al. Hum Reprod Update. 2021 Oct 18;27(6):1115-1150. doi: 10.1093/humupd/dmab026. Hum Reprod Update. 2021. PMID: 34432008 Clinical Trial.

2

Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene.

Simoncini T, Genazzani AR, Liao JK. Simoncini T, et al. Among authors: genazzani ar. Circulation. 2002 Mar 19;105(11):1368-73. doi: 10.1161/hc1102.105267. Circulation. 2002. PMID: 11901050

3

Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator.

Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, Genazzani AR. Simoncini T, et al. Among authors: genazzani ar. Endocrinology. 2002 Jun;143(6):2052-61. doi: 10.1210/endo.143.6.8749. Endocrinology. 2002. PMID: 12021169

4

Clinical relevance of the HERS trial.

Gambacciani M, Rosano GM, Monteleone P, Fini M, Genazzani AR. Gambacciani M, et al. Among authors: genazzani ar. Lancet. 2002 Aug 24;360(9333):641. doi: 10.1016/S0140-6736(02)09789-1. Lancet. 2002. PMID: 12241954 No abstract available.

5

Hormonal influence on the central nervous system.

Genazzani AR, Monteleone P, Gambacciani M. Genazzani AR, et al. Maturitas. 2002 Aug 30;43 Suppl 1:S11-7. doi: 10.1016/s0378-5122(02)00144-5. Maturitas. 2002. PMID: 12361884 Review.

6

Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.

Gambacciani M, Monteleone P, Vitale C, Silvestri A, Fini M, Genazzani AR, Rosano GM. Gambacciani M, et al. Among authors: genazzani ar. Maturitas. 2002 Oct 25;43(2):117-23. doi: 10.1016/s0378-5122(02)00184-6. Maturitas. 2002. PMID: 12385860 Clinical Trial.

7

Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase.

Simoncini T, Fornari L, Mannella P, Varone G, Caruso A, Liao JK, Genazzani AR. Simoncini T, et al. Among authors: genazzani ar. Steroids. 2002 Nov;67(12):935-9. doi: 10.1016/s0039-128x(02)00040-5. Steroids. 2002. PMID: 12398989 Review.

8

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR. Gambacciani M, et al. Among authors: genazzani ar. Maturitas. 2003 Feb 25;44(2):157-63. doi: 10.1016/s0378-5122(02)00327-4. Maturitas. 2003. PMID: 12590012 Clinical Trial.

9

Non-genomic actions of sex steroid hormones.

Simoncini T, Genazzani AR. Simoncini T, et al. Among authors: genazzani ar. Eur J Endocrinol. 2003 Mar;148(3):281-92. doi: 10.1530/eje.0.1480281. Eur J Endocrinol. 2003. PMID: 12611608 Review.

10

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Simoncini T, et al. Among authors: genazzani ar. Endocrinology. 2003 Aug;144(8):3449-55. doi: 10.1210/en.2003-0044. Endocrinology. 2003. PMID: 12865324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

863 results

Search Page